A team of scientists led by Rong Lu from USC and Akil A. Merchant from Cedars-Sinai introduced a genetic technology correlating gene expression signatures with cancer progression and chemotherapy resistance in leukemia.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe